799 results on '"Coombes, R. C."'
Search Results
2. Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
3. Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
4. Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
5. Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
6. Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer
7. Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES
8. Fibroblast Growth Factors and Their Receptors in Breast and Prostate Cancer
9. NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer
10. Aromatase Inhibitors and Their Use in the Adjuvant Setting
11. David Vigushin
12. The role of genes co-amplified with nicastrin in breast invasive carcinoma
13. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
14. New Endocrine Agents for the Treatment of Breast Cancer
15. Tumour Markers In Malignancies
16. Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)—first results from PathIES†
17. LMTK3 is implicated in endocrine resistance via multiple signaling pathways
18. FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance
19. SUMOylation inhibits FOXM1 activity and delays mitotic transition
20. FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
21. Effects of aromatase inhibitors and body mass index on steroid hormone levels in women with early and advanced breast cancer
22. The DEAD-box protein p72 regulates ERα-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERα-positive breast cancer
23. Phase I study of TNFα AutoVaccIne in Patients with metastatic cancer
24. Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF
25. The nuclear oxysterol receptor LXRα is expressed in the normal human breast and in breast cancer
26. A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen
27. Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo
28. An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)
29. A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy
30. Increased expression of fibroblast growth factor 8 in human breast cancer
31. Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen
32. The Secretion of Calcitonin by Human Tumours
33. The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer
34. Analysis of Cell-Free Plasma DNA from Breast Cancer Patients
35. Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer
36. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
37. Design and Rationale of a Randomised Comparison of Cyclophosphamide, Methotrexate and Fluorouracil vs Fluorouracil, Epirubicin and Cyclophosphamide in Node-Positive Premenopausal Women with Operable Breast Cancer: A Trial of the International Collaborative Cancer Group (ICCG)
38. High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial
39. Tamoxifen-related porphyria cutanea tarda
40. Resolution of late-onset asthma following high-dose chemotherapy
41. Letter 1: Bone marrow micrometastasis in breast cancer (Br J Surg 2003; 90: 290–301)
42. Estrogen-receptor-directed neoadjuvant therapy for breast cancer: Results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy
43. Mid-infrared imaging in breast cancer tissue: an objective measure of grading breast cancer biopsies
44. New Endocrine Agents for the Treatment of Breast Cancer
45. Conservative management of fibroadenoma of the breast
46. mRNA variants of fibroblast growth factor receptor type 1 and recurrence of breast cancer
47. Failure To Detect Intra-Abdominal Metastases From Breast Cancer: A Case For Staging Laparotomy
48. Secretion Of Immunoreactive Calcitonin By Human Breast Carcinomas
49. Aminoglutethimide (With Hydrocortisone) Induced Agranulocytosis In Primary Breast Cancer
50. Diagnosing Breast Carcinoma In Young Women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.